E. Ohman J or Asset Management AB Increases Stake in Surgery Partners, Inc. (NASDAQ:SGRY)

E. Ohman J or Asset Management AB lifted its stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 31.0% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 886,088 shares of the company's stock after purchasing an additional 209,888 shares during the period. E. Ohman J or Asset Management AB owned 0.70% of Surgery Partners worth $28,567,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the stock. Quarry LP increased its stake in Surgery Partners by 133.1% during the 2nd quarter. Quarry LP now owns 3,082 shares of the company's stock worth $73,000 after purchasing an additional 1,760 shares in the last quarter. DekaBank Deutsche Girozentrale increased its stake in shares of Surgery Partners by 102.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company's stock worth $80,000 after purchasing an additional 1,375 shares during the last quarter. EntryPoint Capital LLC boosted its stake in shares of Surgery Partners by 257.1% during the 1st quarter. EntryPoint Capital LLC now owns 6,399 shares of the company's stock worth $191,000 after acquiring an additional 4,607 shares during the period. Creative Planning acquired a new position in shares of Surgery Partners in the third quarter valued at $258,000. Finally, Capstone Investment Advisors LLC raised its holdings in Surgery Partners by 38.7% in the 1st quarter. Capstone Investment Advisors LLC now owns 9,151 shares of the company's stock valued at $273,000 after acquiring an additional 2,551 shares during the period.

Surgery Partners Stock Down 4.5 %

NASDAQ SGRY traded down $1.40 during mid-day trading on Friday, hitting $29.47. The company's stock had a trading volume of 753,361 shares, compared to its average volume of 939,796. Surgery Partners, Inc. has a twelve month low of $22.05 and a twelve month high of $36.92. The firm has a market capitalization of $3.75 billion, a price-to-earnings ratio of -108.51, a PEG ratio of 2.45 and a beta of 2.75. The company's 50 day simple moving average is $31.26 and its 200 day simple moving average is $28.05. The company has a current ratio of 1.83, a quick ratio of 1.69 and a debt-to-equity ratio of 0.96.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $0.21 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.01. The company had revenue of $762.10 million for the quarter, compared to analyst estimates of $735.94 million. Surgery Partners had a positive return on equity of 2.96% and a negative net margin of 1.17%. The company's revenue for the quarter was up 14.2% on a year-over-year basis. During the same quarter last year, the company earned $0.25 earnings per share. Analysts anticipate that Surgery Partners, Inc. will post 0.84 earnings per share for the current year.

Analysts Set New Price Targets

SGRY has been the topic of a number of analyst reports. StockNews.com lowered shares of Surgery Partners from a "hold" rating to a "sell" rating in a research report on Wednesday, August 7th. KeyCorp initiated coverage on shares of Surgery Partners in a research report on Friday, October 11th. They issued a "sector weight" rating on the stock. Citigroup lowered their price objective on Surgery Partners from $38.00 to $36.00 and set a "buy" rating for the company in a research note on Wednesday, August 7th. UBS Group began coverage on Surgery Partners in a research report on Monday, October 14th. They set a "buy" rating and a $38.00 target price for the company. Finally, Benchmark reaffirmed a "buy" rating and issued a $50.00 price objective on shares of Surgery Partners in a research note on Monday, August 26th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $39.63.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.